Esperion Therapeutics Files 2024 10-K
Ticker: ESPR · Form: 10-K · Filed: Mar 7, 2025 · CIK: 1434868
| Field | Detail |
|---|---|
| Company | Esperion Therapeutics, Inc. (ESPR) |
| Form Type | 10-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Esperion's 2024 10-K is in. Full year financials out.
AI Summary
Esperion Therapeutics, Inc. filed its 2024 10-K on March 7, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly HDL Therapeutics Inc., is based in Ann Arbor, MI. Key financial data and operational details for the period are presented in this annual report.
Why It Matters
This filing provides a comprehensive overview of Esperion Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Esperion Therapeutics faces inherent risks related to drug development, regulatory approvals, market competition, and financial performance.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period covered by the 10-K)
- 2025-03-07 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Esperion Therapeutics, Inc. (company) — Filer of the 10-K
- HDL THERAPEUTICS INC (company) — Former company name
- Ann Arbor, MI (location) — Company headquarters
- 2024-12-31 (date) — Fiscal year end
- 2025-03-07 (date) — Filing date
FAQ
What is Esperion Therapeutics' primary business?
Esperion Therapeutics, Inc. is primarily involved in the pharmaceutical preparations industry, as indicated by its SIC code [2834].
When did Esperion Therapeutics change its name from HDL Therapeutics Inc.?
The company's name change from HDL Therapeutics Inc. to Esperion Therapeutics, Inc. occurred on 2008-05-13.
What is the SEC file number for Esperion Therapeutics?
The SEC file number for Esperion Therapeutics is 001-35986.
Where is Esperion Therapeutics located?
Esperion Therapeutics, Inc. is located at 3891 Ranchero Drive, Suite 150, Ann Arbor, MI 48108.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 7, 2025 regarding Esperion Therapeutics, Inc. (ESPR).